Abbott wins appeal to restore glucose monitoring patent

A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Abbott appeals ‘baffling’ decision in glucose monitoring device feud

16 December 2025 UK court hears claims that a delay and construction inconsistency led to the alleged wrongful invalidation of a patent at the heart of a global dispute.

Europe

UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

12 December 2024 Paris Local Division revokes Dexcom patent and dismisses infringement action against rival | UPC revoked two other patents belonging to medical device company earlier in 2024.

Unified Patent Court

UPC’s second infringement decision revokes patent in Europe

9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients.

More features

Regeneron v Alvotech: The big impact

SCOTUS shuts the door on Entresto ‘after-arising technology’ review

Morgan Lewis continues coast-to-coast US expansion with life sciences specialist

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

Abbott appeals ‘baffling’ decision in glucose monitoring device feud

Beyond traditional IP: A comprehensive AI strategy for life sciences

Winston & Strawn and Taylor Wessing UK plan transatlantic combo

Diagnosis: What’s holding back UK life sciences?

Abbott wins appeal to restore glucose monitoring patent

More on this story

Editor's picks

Editor's picks

More features